Genomic Valley Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Genomic Valley Biotech has a total shareholder equity of ₹35.8M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹68.0M and ₹32.2M respectively. Genomic Valley Biotech's EBIT is ₹10.1M making its interest coverage ratio -23.9. It has cash and short-term investments of ₹408.6K.
Key information
0%
Debt to equity ratio
₹0
Debt
Interest coverage ratio | -23.9x |
Cash | ₹408.61k |
Equity | ₹35.77m |
Total liabilities | ₹32.24m |
Total assets | ₹68.01m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539206's short term assets (₹54.4M) exceed its short term liabilities (₹32.2M).
Long Term Liabilities: 539206's short term assets (₹54.4M) exceed its long term liabilities (₹2.2K).
Debt to Equity History and Analysis
Debt Level: 539206 is debt free.
Reducing Debt: 539206 has no debt compared to 5 years ago when its debt to equity ratio was 16.5%.
Debt Coverage: 539206 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 539206 has no debt, therefore coverage of interest payments is not a concern.